The Limited Times

Now you can see non-English news...

Preliminary research results presented to Bennett: After receiving the fourth vaccine, there is a fivefold increase in the level of antibodies | Israel today

2022-01-04T13:25:17.043Z


The Prime Minister visited Sheba Medical Center today, where a study was conducted regarding the permanent vaccine dose against Corona: "We are here, studying the data and giving them to the whole world" • Prof. Gili Regev-Yohai who conducted the study: "The results of the study indicate the safety of the fourth vaccine "


Prime Minister Bennett arrived today (Tuesday) on a tour of impression about the Sheba Medical Center deployment scenario of a wave of serious injury can occur. Commended the


study made corona field hospital, which influence decision makers around the world and how to manage the epidemic: "We're here, learn the database And you give them to the whole world, and through your dedicated work you save lives, no less. "

"New layer of protection": Bennett revealed that a fourth vaccine has been approved for people aged 60 and over in Israel // Photo: GPO

During his visit, the Prime Minister was presented with preliminary results from the first study of its kind in the world, led by Sheba on the efficacy and safety of the fourth dose of the vaccine.


"I am pleased to announce together with Prof. Yitzhak Kreiss and Prof. Gili Regev-Yohai, who are conducting the study, that the initial research regarding the fourth dose shows that within a week of receiving the fourth vaccine there is an almost fivefold increase in blood antibodies," he said. "Apparently, it will express a much higher level of protection than without the same injection. A high level of protection both in relation to infection and contagion and in relation to serious illness. In simple Hebrew - the fourth vaccine is safe, that's for sure.


The fourth vaccine most likely works."

The vaccine is launched on Wednesday // Photo: Oren Ben Hakon,

The study, led by Prof. Gili Regev-Yohai - Director of the


Infection

Prevention

and Control

Unit in

Sheba, in collaboration with the Ministry of Health, was approved by the


Helsinki

Committee

- the highest committee for human trials.

Prof. Gili Regev-Yohai said: "These preliminary findings join


preliminary

results

obtained after the administration of the fourth dose in terms of side effects


and which also indicate the safety of the fourth dose. This study will yield


additional information in the coming days and weeks."

Were we wrong?

Fixed!

If you found an error in the article, we'll be happy for you to share it with us

Source: israelhayom

All life articles on 2022-01-04

You may like

News/Politics 2024-04-04T13:28:32.406Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.